Thus, our results indicate that tumor cells sensitized by sirolimus become more dependent than normal cells on BCL2 and MCL1 for sustained survival, thus increasing their susceptibility to apoptosis in the absence of these key pro-survival proteins. The gene discussed is MCL1; the disease is neoplasm.